Supplier profile
PHOENIX lékárenský velkoobchod, s.r.o.
Every public-sector award we hold for this supplier, across Czechia, from 22 Jun 2017 to 3 Oct 2026.
Awards won
2,160
all time
Attributed value
CZK 29.8bn
837 shared, unvalued
Buyers
63
public bodies
Active
2017–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Fakultní nemocnice Brno | 311 | CZK 7.1bn |
| Fakultní nemocnice Olomouc | 248 | CZK 2.9bn |
| Fakultní nemocnice Hradec Králové | 209 | CZK 2.7bn |
| Fakultní nemocnice Bulovka | 185 | CZK 3.3bn |
| Fakultní nemocnice u sv. Anny v Brně | 119 | CZK 850.5m |
| Nemocnice Na Homolce | 86 | CZK 16.8m |
| Fakultní nemocnice Plzeň | 82 | CZK 905.0m |
| Institut klinické a experimentální medicíny | 79 | CZK 2.9bn |
| Moravskoslezský kraj | 64 | not attributable |
| Krajská zdravotní, a.s. | 63 | CZK 549.6m |
What they win
Awards
Showing 526–550 of 2,160 awards we hold
- Czechia – Medical preparations excluding dental consumables – Léčiva pro NEMCB (032025) ↗Nemocnice České Budějovice, a.s.shared awardawarded 30 Apr 2025
- Czechia – Medicinal products for the blood and blood-forming organs – Léčivé přípravky pro krev a krvetvorné orgány 2025 ↗Fakultní nemocnice Plzeňshared awardawarded 29 Apr 2025
- Czechia – Various medicinal products – Léčivé přípravky 2025-II ↗Fakultní nemocnice Plzeňshared awardawarded 29 Apr 2025
- Czechia – Antineoplastic agents – Léčivý přípravek s obsahem účinné látky enzalutamid 2025 ↗Fakultní nemocnice Plzeň£286.0mawarded 29 Apr 2025
- Czechia – Medicinal products for obstructive airway diseases – Dodávky léků – Léčivá látka tezepelumab – ATC R03DX11 ↗Fakultní Thomayerova nemocnice£17.5mawarded 29 Apr 2025
- Czechia – Pituitary, hypothalamic hormones and analogues – Léčivé přípravky s obsahem terlipressinu a somatropinu ↗Fakultní nemocnice Hradec Králové£78.4mawarded 29 Apr 2025
- Czechia – Antineoplastic agents – Výzva č. 65 L01XD04 - KYSELINA AMINOLEVULOVÁ ↗Městská nemocnice Ostrava, příspěvková organizaceawarded 26 Apr 2025
- Czechia – Antimycotics for systemic use – LP S OBSAHEM VORIKONAZOLU TBL. 2025 ↗Fakultní nemocnice Olomoucshared awardawarded 26 Apr 2025
- Czechia – Medicinal products for the nervous system – Výzva č. 63 N02CD05 - EPTINEZUMAB ↗Městská nemocnice Ostrava, příspěvková organizaceawarded 26 Apr 2025
- Czechia – Antineoplastic and immunomodulating agents – LP s obsahem tukatinibu 2025 ↗Fakultní nemocnice Olomouc£15.7mawarded 25 Apr 2025
- Czechia – Pharmaceutical products – FN Motol - Dynamický nákupní systém na dodávky léčivých přípravků ↗Fakultní nemocnice v Motoleshared awardawarded 25 Apr 2025
- Czechia – Medicinal products for the blood and blood-forming organs – Léčivé přípravky pro krev – Kangrelor I. ↗Institut klinické a experimentální medicíny£2.2mawarded 25 Apr 2025
- Czechia – Pharmaceutical products – DYNAMICKÝ NÁKUPNÍ SYSTÉM NA DODÁVKY LÉČIVÝCH PŘÍPRAVKŮ, VÝŽIV A VYBRANÝCH ZDRAVOTNICKÝCH PROSTŘEDKŮ ↗Fakultní nemocnice Bulovkaawarded 25 Apr 2025
- Czechia – Pharmaceutical products – Léčivý přípravek s účinnou látkou NATALIZUMAB ↗Nemocnice Pardubického kraje, a.s.£31.3mawarded 25 Apr 2025
- Czechia – Pharmaceutical products – DYNAMICKÝ NÁKUPNÍ SYSTÉM NA DODÁVKY LÉČIVÝCH PŘÍPRAVKŮ, VÝŽIV A VYBRANÝCH ZDRAVOTNICKÝCH PROSTŘEDKŮ ↗Fakultní nemocnice Bulovkaawarded 25 Apr 2025
- Czechia – Medical preparations excluding dental consumables – Léčiva pro JIHNEM (032025) ↗Jihočeské nemocnice, a.s.shared awardawarded 24 Apr 2025
- Czechia – Medical preparations excluding dental consumables – Léčiva pro JIHNEM (072025) - V08AB02 JOHEXOL ↗Jihočeské nemocnice, a.s.£21.5mawarded 24 Apr 2025
- Czechia – Medical preparations excluding dental consumables – Léčiva pro JIHNEM (022025) ↗Jihočeské nemocnice, a.s.shared awardawarded 24 Apr 2025
- Czechia – Pharmaceutical products – DODÁVKY LÉČIVÝCH PŘÍPRAVKŮ II. – zavedení dynamického nákupního systému ↗Fakultní nemocnice Ostravashared awardawarded 23 Apr 2025
- Czechia – Medicinal products for the alimentary tract and metabolism – DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ - Únor_1/2025 –PEGUNIGALSIDASA ALFA ↗Všeobecná fakultní nemocnice v Prazeawarded 18 Apr 2025
- Czechia – Antineoplastic and immunomodulating agents – Cytostatika 2025 ↗Fakultní nemocnice Plzeňshared awardawarded 18 Apr 2025
- Czechia – Antibacterials for systemic use – AMOXICILIN A INHIBITORY BETA-LAKTAMASY 202 ↗Fakultní nemocnice Olomoucshared awardawarded 18 Apr 2025
- Czechia – Antineoplastic and immunomodulating agents – Imunopreparáty 2025 ↗Fakultní nemocnice Plzeňshared awardawarded 17 Apr 2025
- Czechia – Pharmaceutical products – Léčivé přípravky [2025–2028] ↗Masarykův onkologický ústavshared awardawarded 17 Apr 2025
- Czechia – Endocrine therapy medicinal products – Léčivé přípravky s obsahem leuprorelinu a triptorelinu ↗Fakultní nemocnice Hradec Královéshared awardawarded 16 Apr 2025
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.